Metabolites and derivatives of ambrisentan

Details for Australian Patent Application No. 2008282773 (hide)

Owner GILEAD COLORADO, INC. ABBOTT GMBH & KG. CO.

Inventors Melvin Jr., Lawrence S.; Ullrich, Martina; Hege, Hans-guenther; Weymann, Jurgen

Agent EF WELLINGTON & CO

Pub. Number AU-A-2008282773

PCT Pub. Number WO2009/017777

Priority 60/953,053 31.07.07 US

Filing date 31 July 2008

Wipo publication date 5 February 2009

International Classifications

C07D 239/34 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/505 (2006.01) - Pyrimidines

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

18 February 2010 PCT application entered the National Phase

  PCT publication WO2009/017777 Priority application(s): WO2009/017777

1 April 2010 Alteration of Name

  The name of the applicant has been altered to GILEAD COLORADO, INC.; ABBOTT GMBH & CO. KG.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008282777-Modified vinylamine-containing polymers as additives in papermaking

2008282749-Compositions including androgen receptor degradation (ARD) enhancers and methods of prophylactic or therapeutic treatment of skin disorders and hair loss